Cogstate Ltd (AU:CGS) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nervous system disease assessments, marking a significant strategic expansion for the company. This collaboration is expected to boost Cogstate’s sales, with the first contract anticipated soon. Additionally, Cogstate’s recent financial performance shows promising growth, supported by a new share buyback initiative.
For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.
